Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Account Payables
Amounts the company owes suppliers for goods and services received.
Translational Development Acquisition Corp.NASDAQ: TDAC
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables remains negative
Q1 FY2026 account payables was $0, compared with $225.48K a year earlier.
Context
- Account payables amounted to 0.0% of total assets at the end of Q1 FY2026, down 0.1 pp from a year earlier.
- Account payables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 162.31K USD
- Year-over-year change
- +902.6%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 162.31K | +902.6% |
| FY2024 | 2024-12-31 | 16.19K | +1193.1% |
| FY2023 | 2023-12-31 | 1.25K | — |
| FY2022 | 2022-12-31 | 0 | — |
Account Payables vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 account payables of $0 is the 2nd highest of the 7 companies compared; the peer median is $0.
- Its year-over-year change of -100.0% is the highest of 2, against a peer median of -100.0%.
- Account payables amounts to 0.0% of total assets for TDAC, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
MACIMelar Acquisition Corp. I | Mar 2026 | $1.19M | — | — | 0.7% |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $0 | -100.0% | — | 0.0% |
| Jun 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding TDAC) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.